Pharmacogenomics in Drug Discovery and Development
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Summary: | XIII, 487 p. text |
| Language: | English |
| Published: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2008.
|
| Edition: | 1st ed. 2008. |
| Series: | Methods in Molecular Biology,
448 |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-1-59745-205-2 |
| Format: | Electronic Book |
Table of Contents:
- The Integration of Personalized and Systems Medicine
- Applications of Microarrays and Biochips in Pharmacogenomics
- Confounding in Genetic Association Studies and Its Solutions
- Pharmacogenetics of Membrane Transporters
- Pharmacogenomics of Drug-Metabolizing Enzymes and Drug Transporters in Chemotherapy
- Pharmacogenomics of G Protein-Coupled Receptor
- G Protein-Coupled Receptors Disrupted in Human Genetic Disease
- G Protein-Coupled Receptor Pharmacogenetics
- Epigenetic Alterations of the Dopaminergic System in Major Psychiatric Disorders
- Pharmacogenomics in Alzheimer's Disease
- Pharmacogenetics of Asthma
- From SNPs to Functional Studies in Cardiovascular Pharmacogenomics
- Pharmacogenomics in Gastrointestinal Disorders
- Pharmacogenomics in Rheumatoid Arthritis
- Cancer Pharmacogenetics
- Pharmacogenomics in the Preclinical Development of Vaccines
- Pharmacogenomics in the Evaluation of Efficacy and Adverse Events During Clinical Development of Vaccines.